Marty Makary resigned as FDA commissioner on Tuesday after a turbulent tenure at the head of the agency. The Endpoints and Financial Times teams sat down at the US Pharma and Biotech Summit on Thursday to talk about his tenure, his downfall, and where the FDA goes from here.
Stay ahead of biopharma. Get the Main Edition in your inbox M-F at 11:30 AM ET. Sign up: https://shorturl.at/OBB3D

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör Endpoints News. Innehållet i podden är skapat av Endpoints News och inte av, eller tillsammans med, Poddtoppen.